More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

by | Jul 19, 2017 | HempMeds Brasil, Press Releases

Brazilian Doctors Have Been Prescribing RSHO™ to Treat Patients Suffering From Effects of ALS and Psoriasis SAN DIEGO, July 19, 2017 — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds®...
Medical Marijuana, Inc. Reports First Quarter 2017 Financial Results and Operational Highlights

Medical Marijuana, Inc. Reports First Quarter 2017 Financial Results and Operational Highlights

by | Jun 5, 2017 | Axim Biotechnologies, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Kannaway, Press Releases

SAN DIEGO, June 5, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTCPINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the first quarter ending March 31, 2017, and an overview of recent...

Subscribe for Company Updates

* indicates required

Follow us on

social networks

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.